Xiao-Yan Fu (Xiaoyan Fu)

Years Active: 2020-2024
Publications (10 Years): 5

Taishan Medical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Taishan Medical University Sep 10 2014

China

PHD :: Basic Medicine

Publications

Wang Chen, Pida Hao, Xiaotong Feng, Xiaotong Feng, Xuan Zhao, Jincheng Wu, Zixiang Gong, Jinli Zhang, Xiao-Yan Fu, Xianjun Wang
Methylseleninic acid inhibits human glioma growth in vitro and in vivo by triggering ROS-dependent oxidative damage and apoptosis. Metabolic brain disease 39 (4) (2024)
Wang Chen, Pida Hao, Xiaotong Feng, Xiaotong Feng, Xuan Zhao, Jincheng Wu, Zixiang Gong, Jinli Zhang, Xiao-Yan Fu, Xianjun Wang
Methylseleninic acid inhibits human glioma growth in vitro and in vivo by triggering ROS-dependent oxidative damage and apoptosis. Metabolic brain disease (2024)
Wang Chen, Pida Hao, Xiaotong Feng, Xiaotong Feng, Xuan Zhao, Jincheng Wu, Zixiang Gong, Jinli Zhang, Xiao-Yan Fu, Xianjun Wang
Methylseleninic acid inhibits human glioma growth in vitro and in vivo by triggering ROS-dependent oxidative damage and apoptosis. Metabolic brain disease 39 (4) (2024)
Wang Chen, Pida Hao, Xiaotong Feng, Xiaotong Feng, Xuan Zhao, Jincheng Wu, Zixiang Gong, Jinli Zhang, Xiao-Yan Fu, Xianjun Wang
Methylseleninic acid inhibits human glioma growth in vitro and in vivo by triggering ROS-dependent oxidative damage and apoptosis. Metabolic brain disease 39 (4) (2024)
Wen-Qiang Cao, Xiao-Qian Zhai, Ji-Wei Ma, Xue-Qi Fu, Bai-Song Zhao, Pu Zhang, Xiao-Yan Fu
Natural borneol sensitizes human glioma cells to cisplatin-induced apoptosis by triggering ROS-mediated oxidative damage and regulation of MAPKs and PI3K/AKT pathway. Pharmaceutical biology 58 (1) (2020)

Xiao-Yan Fu.css-eqlu8i{font-size:small;padding-left:4px;} (Xiaoyan Fu)